Home Cart Sign in  
Chemical Structure| 21967-41-9 Chemical Structure| 21967-41-9

Structure of Baicalin
CAS No.: 21967-41-9

Chemical Structure| 21967-41-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Baicalin, a flavonoid glycoside, is an allosteric activator of carnitine palmitoyltransferase 1 (CPT1). It reduces the expression of NF-κB.

Synonyms: Baicalein 7-O-β-D-glucuronide; Baicalein 7-glucuronide; NSC-661431

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Baicalin

CAS No. :21967-41-9
Formula : C21H18O11
M.W : 446.36
SMILES Code : O[C@H]([C@H]([C@@H]([C@@H](C(O)=O)O1)O)O)[C@@H]1OC2=C(O)C(O)=C3C(C=C(C4=CC=CC=C4)OC3=C2)=O
Synonyms :
Baicalein 7-O-β-D-glucuronide; Baicalein 7-glucuronide; NSC-661431
MDL No. :MFCD00134418
InChI Key :IKIIZLYTISPENI-ZFORQUDYSA-N
Pubchem ID :64982

Safety of Baicalin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Baicalin

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
KGN granulosa cell line 10 μM 72 hours Improved granulosa cell viability J Ovarian Res. 2022 Mar 17;15(1):34
Human primary granulosa cells 10 μM 72 hours Improved granulosa cell viability and inhibited apoptosis, possibly related to upregulation of Bcl-2 and downregulation of Bax and Caspase 3 J Ovarian Res. 2022 Mar 17;15(1):34

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ICR and BALB/c mice Histamine- or compound 48/80-induced scratching behavior model Oral or intraperitoneal administration 20 and 50 mg/kg 1 or 5 hours before treatment To evaluate the anti-pruritic effects of baicalin and its metabolites. Oral administration of baicalin 5 hours before treatment showed more potent inhibition on histamine- or compound 48/80-induced scratching behavior. Baicalein and oroxylin A were more effective when administered intraperitoneally. Acta Pharmacol Sin. 2010 Jun;31(6):718-24

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.24mL

0.45mL

0.22mL

11.20mL

2.24mL

1.12mL

22.40mL

4.48mL

2.24mL

References

 

Historical Records

Categories